phosphatidylcholines has been researched along with indinavir sulfate in 2 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (indinavir sulfate) | Trials (indinavir sulfate) | Recent Studies (post-2010) (indinavir sulfate) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 1,834 | 328 | 146 |
Protein | Taxonomy | phosphatidylcholines (IC50) | indinavir sulfate (IC50) |
---|---|---|---|
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (BRU ISOLATE) | 0.0004 | |
Gag polyprotein | HIV-1 M:B_MN | 0.02 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.2 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.0261 | |
Substance-K receptor | Homo sapiens (human) | 5.101 | |
Thromboxane-A synthase | Homo sapiens (human) | 1.851 | |
Protease | Human immunodeficiency virus 1 | 0.0349 | |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.8 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 3.8 | |
Protease | Human immunodeficiency virus 1 | 0.0044 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, D; Bui, T; Ho, RJ; Hu, SL; Kinman, L; Larsen, K; Morton, WR; Tsai, CC | 1 |
Goparaboina, S; Kandadi, P; Syed, MA; Veerabrahma, K | 1 |
2 other study(ies) available for phosphatidylcholines and indinavir sulfate
Article | Year |
---|---|
Optimization of lipid-indinavir complexes for localization in lymphoid tissues of HIV-infected macaques.
Topics: Animals; Anti-HIV Agents; CD4 Lymphocyte Count; Cell Line; Disease Models, Animal; Drug Carriers; HIV Infections; HIV-2; Hydrogen-Ion Concentration; Indinavir; Injections, Subcutaneous; Lipids; Lymph Nodes; Lymphoid Tissue; Macaca nemestrina; Nanostructures; Phosphatidylcholines; RNA, Viral; Tissue Distribution | 2006 |
Brain specific delivery of pegylated indinavir submicron lipid emulsions.
Topics: Animals; Brain; Cholesterol; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Compounding; Drug Stability; Excipients; Fat Emulsions, Intravenous; HIV Protease Inhibitors; Indinavir; Lipids; Male; Mice; Nanoparticles; Particle Size; Phosphatidylcholines; Polyethylene Glycols; Sonication; Soybean Oil; Tissue Distribution | 2011 |